485 related articles for article (PubMed ID: 30335963)
1. Stimuli-Responsive Nano-Architecture Drug-Delivery Systems to Solid Tumor Micromilieu: Past, Present, and Future Perspectives.
El-Sawy HS; Al-Abd AM; Ahmed TA; El-Say KM; Torchilin VP
ACS Nano; 2018 Nov; 12(11):10636-10664. PubMed ID: 30335963
[TBL] [Abstract][Full Text] [Related]
2. Redox-responsive nano-carriers as tumor-targeted drug delivery systems.
Raza A; Hayat U; Rasheed T; Bilal M; Iqbal HMN
Eur J Med Chem; 2018 Sep; 157():705-715. PubMed ID: 30138802
[TBL] [Abstract][Full Text] [Related]
3. Stimuli-responsive Smart Liposomes in Cancer Targeting.
Jain A; Jain SK
Curr Drug Targets; 2018 Feb; 19(3):259-270. PubMed ID: 26853324
[TBL] [Abstract][Full Text] [Related]
4. Classification of stimuli-responsive polymers as anticancer drug delivery systems.
Taghizadeh B; Taranejoo S; Monemian SA; Salehi Moghaddam Z; Daliri K; Derakhshankhah H; Derakhshani Z
Drug Deliv; 2015 Feb; 22(2):145-55. PubMed ID: 24547737
[TBL] [Abstract][Full Text] [Related]
5. Recent Advances in pH-Sensitive Polymeric Nanoparticles for Smart Drug Delivery in Cancer Therapy.
Lim EK; Chung BH; Chung SJ
Curr Drug Targets; 2018 Feb; 19(4):300-317. PubMed ID: 27262486
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound-mediated nano drug delivery for treating cancer: Fundamental physics to future directions.
Moradi Kashkooli F; Jakhmola A; Hornsby TK; Tavakkoli JJ; Kolios MC
J Control Release; 2023 Mar; 355():552-578. PubMed ID: 36773959
[TBL] [Abstract][Full Text] [Related]
7. Stimuli-responsive polymeric nanoparticles for nanomedicine.
Crucho CI
ChemMedChem; 2015 Jan; 10(1):24-38. PubMed ID: 25319803
[TBL] [Abstract][Full Text] [Related]
8. Nanotheranostic Pluronic-Like Polymeric Micelles: Shedding Light into the Dark Shadows of Tumors.
Domingues C; Alvarez-Lorenzo C; Concheiro A; Veiga F; Figueiras A
Mol Pharm; 2019 Dec; 16(12):4757-4774. PubMed ID: 31633939
[TBL] [Abstract][Full Text] [Related]
9. pH-sensitive nano-systems for drug delivery in cancer therapy.
Liu J; Huang Y; Kumar A; Tan A; Jin S; Mozhi A; Liang XJ
Biotechnol Adv; 2014; 32(4):693-710. PubMed ID: 24309541
[TBL] [Abstract][Full Text] [Related]
10. Advances in Functionalized Mesoporous Silica Nanoparticles for Tumor Targeted Drug Delivery and Theranostics.
Zhang W; Liu M; Liu A; Zhai G
Curr Pharm Des; 2017; 23(23):3367-3382. PubMed ID: 27784244
[TBL] [Abstract][Full Text] [Related]
11. Endogenous stimuli-responsive linkers in nanoliposomal systems for cancer drug targeting.
Faal Maleki M; Jafari A; Mirhadi E; Askarizadeh A; Golichenari B; Hadizadeh F; Jalilzadeh Moghimi SM; Aryan R; Mashreghi M; Jaafari MR
Int J Pharm; 2019 Dec; 572():118716. PubMed ID: 31705978
[TBL] [Abstract][Full Text] [Related]
12. Strategies To Design and Synthesize Polymer-Based Stimuli-Responsive Drug-Delivery Nanosystems.
Qin X; Li Y
Chembiochem; 2020 May; 21(9):1236-1253. PubMed ID: 31889379
[TBL] [Abstract][Full Text] [Related]
13. pH-responsive self-assembled nanoparticles for tumor-targeted drug delivery.
Sun H; Li X; Liu Q; Sheng H; Zhu L
J Drug Target; 2024 Jul; 32(6):672-706. PubMed ID: 38682299
[TBL] [Abstract][Full Text] [Related]
14. Designing Stimuli-Responsive Upconversion Nanoparticles that Exploit the Tumor Microenvironment.
Ovais M; Mukherjee S; Pramanik A; Das D; Mukherjee A; Raza A; Chen C
Adv Mater; 2020 Jun; 32(22):e2000055. PubMed ID: 32227413
[TBL] [Abstract][Full Text] [Related]
15. Nanostructures for pH-sensitive Drug Delivery and Magnetic Resonance Contrast Enhancement Systems.
Sun X; Zhang G; Wu Z
Curr Med Chem; 2018; 25(25):3036-3057. PubMed ID: 28393692
[TBL] [Abstract][Full Text] [Related]
16. Smart Drug-Delivery Systems for Cancer Nanotherapy.
Sanchez-Moreno P; Ortega-Vinuesa JL; Peula-Garcia JM; Marchal JA; Boulaiz H
Curr Drug Targets; 2018 Feb; 19(4):339-359. PubMed ID: 27231107
[TBL] [Abstract][Full Text] [Related]
17. Engineering Nanorobots for Tumor-Targeting Drug Delivery: From Dynamic Control to Stimuli-Responsive Strategy.
Huang L; Chen F; Lai Y; Xu Z; Yu H
Chembiochem; 2021 Dec; 22(24):3369-3380. PubMed ID: 34411411
[TBL] [Abstract][Full Text] [Related]
18. Role of pH-responsiveness in the design of chitosan-based cancer nanotherapeutics: A review.
Suarato G; Li W; Meng Y
Biointerphases; 2016 Dec; 11(4):04B201. PubMed ID: 27016506
[TBL] [Abstract][Full Text] [Related]
19. Tumor-Acidity-Cleavable Maleic Acid Amide (TACMAA): A Powerful Tool for Designing Smart Nanoparticles To Overcome Delivery Barriers in Cancer Nanomedicine.
Du JZ; Li HJ; Wang J
Acc Chem Res; 2018 Nov; 51(11):2848-2856. PubMed ID: 30346728
[TBL] [Abstract][Full Text] [Related]
20. Role of integrated cancer nanomedicine in overcoming drug resistance.
Iyer AK; Singh A; Ganta S; Amiji MM
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
